QI
VIVO

QS Investors’s Meridian Bioscience Inc VIVO Stock Holding History

QS Investors’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$372K Hold
16,749
– – ﹤0.01% 855
2021
Q1 		$440K Hold
16,749
– – 0.01% 843
2020
Q4 		$313K Hold
16,749
– – ﹤0.01% 976
2020
Q3 		$285K Sell
16,749
-69,561
-81% -$1.35M ﹤0.01% 941
2020
Q2 		$2.01M Buy
+86,310
New +$1.25M 0.03% 488
2017
Q1 		– Sell
-5,052
Closed -$89K – 2037
2016
Q4 		$89K Buy
5,052
+1,072
+27% +$18.8K ﹤0.01% 1299
2016
Q3 		$77K Buy
3,980
+1,108
+39% +$21.7K ﹤0.01% 1315
2016
Q2 		$56K Buy
2,872
+2,377
+480% +$46.6K ﹤0.01% 1343
2016
Q1 		$10K Buy
495
+389
+367% +$7.67K ﹤0.01% 1432
2015
Q4 		$2K Buy
+106
New +$2.03K ﹤0.01% 1522

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QS Investors's VIVO Position: Q2 2021 in Review

QS Investors held its Meridian Bioscience Inc (VIVO) position steady in Q2 2021 at 16,749 shares worth $372K. The position accounts for ﹤0.01% of the portfolio, ranked #855.

QS Investors first reported a position in VIVO in Q4 2015 and has held it in 10 quarters since. The position peaked at $2.01M in Q2 2020. 189 funds tracked by Wall St. Rank hold VIVO as of Q2 2021.

  • QS Investors held 16,749 shares of Meridian Bioscience Inc worth $372K as of Q2 2021.
  • QS Investors left its Meridian Bioscience Inc share count unchanged in Q2 2021.
  • Meridian Bioscience Inc made up ﹤0.01% of QS Investors's portfolio in Q2 2021, its #855 holding.
  • QS Investors first reported a position in Meridian Bioscience Inc in Q4 2015 and has held it in 10 quarters since.
  • QS Investors's Meridian Bioscience Inc position peaked at $2.01M in Q2 2020.
  • 189 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.